nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—HTR3A—myenteric nerve plexus—systemic scleroderma	0.0531	0.693	CbGeAlD
Procaine—HTR3A—digestive system—systemic scleroderma	0.00402	0.0525	CbGeAlD
Procaine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00364	0.00394	CcSEcCtD
Procaine—SCN10A—lung—systemic scleroderma	0.00362	0.0473	CbGeAlD
Procaine—Nervousness—Captopril—systemic scleroderma	0.00361	0.00391	CcSEcCtD
Procaine—Arthralgia—Mometasone—systemic scleroderma	0.0036	0.0039	CcSEcCtD
Procaine—Somnolence—Pentoxifylline—systemic scleroderma	0.00356	0.00385	CcSEcCtD
Procaine—Apnoea—Methotrexate—systemic scleroderma	0.00353	0.00382	CcSEcCtD
Procaine—Vision blurred—Captopril—systemic scleroderma	0.0035	0.00379	CcSEcCtD
Procaine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00345	0.00374	CcSEcCtD
Procaine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00342	0.0037	CcSEcCtD
Procaine—Angioedema—Captopril—systemic scleroderma	0.0034	0.00368	CcSEcCtD
Procaine—Neuropathy—Prednisone—systemic scleroderma	0.00336	0.00364	CcSEcCtD
Procaine—HTR3A—lung—systemic scleroderma	0.00336	0.0438	CbGeAlD
Procaine—Chills—Azathioprine—systemic scleroderma	0.00334	0.00362	CcSEcCtD
Procaine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00334	0.00362	CcSEcCtD
Procaine—Syncope—Captopril—systemic scleroderma	0.00333	0.00361	CcSEcCtD
Procaine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.0033	0.00358	CcSEcCtD
Procaine—Loss of consciousness—Captopril—systemic scleroderma	0.00327	0.00354	CcSEcCtD
Procaine—Urticaria—Pentoxifylline—systemic scleroderma	0.00318	0.00344	CcSEcCtD
Procaine—Arthralgia—Captopril—systemic scleroderma	0.00316	0.00343	CcSEcCtD
Procaine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00316	0.00343	CcSEcCtD
Procaine—Chills—Leflunomide—systemic scleroderma	0.00316	0.00342	CcSEcCtD
Procaine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00315	0.00341	CcSEcCtD
Procaine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00313	0.00339	CcSEcCtD
Procaine—Bradycardia—Lisinopril—systemic scleroderma	0.00308	0.00333	CcSEcCtD
Procaine—Anaphylactic shock—Captopril—systemic scleroderma	0.00303	0.00329	CcSEcCtD
Procaine—Chills—Mycophenolic acid—systemic scleroderma	0.00301	0.00326	CcSEcCtD
Procaine—Hallucination—Lisinopril—systemic scleroderma	0.00301	0.00326	CcSEcCtD
Procaine—Shock—Captopril—systemic scleroderma	0.00298	0.00323	CcSEcCtD
Procaine—Fatigue—Mometasone—systemic scleroderma	0.00298	0.00323	CcSEcCtD
Procaine—Thrombocytopenia—Captopril—systemic scleroderma	0.00297	0.00322	CcSEcCtD
Procaine—Tachycardia—Captopril—systemic scleroderma	0.00296	0.00321	CcSEcCtD
Procaine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00295	0.00319	CcSEcCtD
Procaine—Leukopenia—Azathioprine—systemic scleroderma	0.0029	0.00314	CcSEcCtD
Procaine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00289	0.00313	CcSEcCtD
Procaine—Vision blurred—Leflunomide—systemic scleroderma	0.00289	0.00313	CcSEcCtD
Procaine—Tension—Mycophenolic acid—systemic scleroderma	0.00287	0.00311	CcSEcCtD
Procaine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00284	0.00307	CcSEcCtD
Procaine—Hypotension—Captopril—systemic scleroderma	0.00284	0.00307	CcSEcCtD
Procaine—Pruritus—Pentoxifylline—systemic scleroderma	0.00283	0.00307	CcSEcCtD
Procaine—BCHE—smooth muscle tissue—systemic scleroderma	0.00282	0.0369	CbGeAlD
Procaine—Tinnitus—Lisinopril—systemic scleroderma	0.00282	0.00305	CcSEcCtD
Procaine—Angioedema—Leflunomide—systemic scleroderma	0.0028	0.00303	CcSEcCtD
Procaine—SLC6A3—lung—systemic scleroderma	0.00279	0.0365	CbGeAlD
Procaine—BCHE—skin of body—systemic scleroderma	0.00279	0.0364	CbGeAlD
Procaine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00276	0.00299	CcSEcCtD
Procaine—Arthralgia—Azathioprine—systemic scleroderma	0.00276	0.00299	CcSEcCtD
Procaine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00275	0.00298	CcSEcCtD
Procaine—Leukopenia—Leflunomide—systemic scleroderma	0.00274	0.00297	CcSEcCtD
Procaine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00274	0.00297	CcSEcCtD
Procaine—Tremor—Mycophenolic acid—systemic scleroderma	0.00274	0.00297	CcSEcCtD
Procaine—Body temperature increased—Mometasone—systemic scleroderma	0.00273	0.00296	CcSEcCtD
Procaine—Chills—Lisinopril—systemic scleroderma	0.00271	0.00294	CcSEcCtD
Procaine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.0027	0.00292	CcSEcCtD
Procaine—Somnolence—Captopril—systemic scleroderma	0.0027	0.00292	CcSEcCtD
Procaine—Agitation—Mycophenolic acid—systemic scleroderma	0.00269	0.00291	CcSEcCtD
Procaine—Dizziness—Pentoxifylline—systemic scleroderma	0.00265	0.00287	CcSEcCtD
Procaine—Hypertension—Leflunomide—systemic scleroderma	0.00265	0.00286	CcSEcCtD
Procaine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00286	CcSEcCtD
Procaine—Erythema—Lisinopril—systemic scleroderma	0.00263	0.00285	CcSEcCtD
Procaine—Syncope—Mycophenolic acid—systemic scleroderma	0.00262	0.00284	CcSEcCtD
Procaine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00262	0.00283	CcSEcCtD
Procaine—Fatigue—Captopril—systemic scleroderma	0.00262	0.00283	CcSEcCtD
Procaine—Arthralgia—Leflunomide—systemic scleroderma	0.00261	0.00282	CcSEcCtD
Procaine—Anxiety—Leflunomide—systemic scleroderma	0.0026	0.00282	CcSEcCtD
Procaine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00259	0.00281	CcSEcCtD
Procaine—Tension—Lisinopril—systemic scleroderma	0.00258	0.0028	CcSEcCtD
Procaine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00257	0.00278	CcSEcCtD
Procaine—Nervousness—Lisinopril—systemic scleroderma	0.00256	0.00277	CcSEcCtD
Procaine—Vomiting—Pentoxifylline—systemic scleroderma	0.00255	0.00276	CcSEcCtD
Procaine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00253	0.00274	CcSEcCtD
Procaine—Rash—Pentoxifylline—systemic scleroderma	0.00252	0.00273	CcSEcCtD
Procaine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00252	0.00273	CcSEcCtD
Procaine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00252	0.00273	CcSEcCtD
Procaine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0025	0.00271	CcSEcCtD
Procaine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00249	0.00269	CcSEcCtD
Procaine—Vision blurred—Lisinopril—systemic scleroderma	0.00248	0.00269	CcSEcCtD
Procaine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00248	0.00269	CcSEcCtD
Procaine—Hypotension—Azathioprine—systemic scleroderma	0.00247	0.00268	CcSEcCtD
Procaine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00247	0.00268	CcSEcCtD
Procaine—Cardiac arrest—Prednisone—systemic scleroderma	0.00247	0.00267	CcSEcCtD
Procaine—Tremor—Lisinopril—systemic scleroderma	0.00247	0.00267	CcSEcCtD
Procaine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00245	0.00265	CcSEcCtD
Procaine—Pruritus—Mometasone—systemic scleroderma	0.00244	0.00265	CcSEcCtD
Procaine—Tachycardia—Leflunomide—systemic scleroderma	0.00244	0.00264	CcSEcCtD
Procaine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00242	0.00262	CcSEcCtD
Procaine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00241	0.00261	CcSEcCtD
Procaine—Angioedema—Lisinopril—systemic scleroderma	0.00241	0.00261	CcSEcCtD
Procaine—Body temperature increased—Captopril—systemic scleroderma	0.0024	0.0026	CcSEcCtD
Procaine—Oedema—Mycophenolic acid—systemic scleroderma	0.00239	0.00258	CcSEcCtD
Procaine—Nausea—Pentoxifylline—systemic scleroderma	0.00238	0.00258	CcSEcCtD
Procaine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00257	CcSEcCtD
Procaine—Diarrhoea—Mometasone—systemic scleroderma	0.00236	0.00256	CcSEcCtD
Procaine—Syncope—Lisinopril—systemic scleroderma	0.00236	0.00256	CcSEcCtD
Procaine—Leukopenia—Lisinopril—systemic scleroderma	0.00236	0.00255	CcSEcCtD
Procaine—Shock—Mycophenolic acid—systemic scleroderma	0.00235	0.00254	CcSEcCtD
Procaine—Hypotension—Leflunomide—systemic scleroderma	0.00234	0.00253	CcSEcCtD
Procaine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00234	0.00253	CcSEcCtD
Procaine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00233	0.00252	CcSEcCtD
Procaine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00231	0.00251	CcSEcCtD
Procaine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00231	0.0025	CcSEcCtD
Procaine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.0023	0.00249	CcSEcCtD
Procaine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00228	0.00247	CcSEcCtD
Procaine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00245	CcSEcCtD
Procaine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00224	0.00243	CcSEcCtD
Procaine—Arthralgia—Lisinopril—systemic scleroderma	0.00224	0.00243	CcSEcCtD
Procaine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00243	CcSEcCtD
Procaine—Anxiety—Lisinopril—systemic scleroderma	0.00223	0.00242	CcSEcCtD
Procaine—BCHE—digestive system—systemic scleroderma	0.00223	0.0291	CbGeAlD
Procaine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00223	0.00241	CcSEcCtD
Procaine—Vomiting—Mometasone—systemic scleroderma	0.0022	0.00238	CcSEcCtD
Procaine—Sweating increased—Prednisone—systemic scleroderma	0.00219	0.00237	CcSEcCtD
Procaine—Rash—Mometasone—systemic scleroderma	0.00218	0.00236	CcSEcCtD
Procaine—Dermatitis—Mometasone—systemic scleroderma	0.00218	0.00236	CcSEcCtD
Procaine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00217	0.00235	CcSEcCtD
Procaine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00234	CcSEcCtD
Procaine—Fatigue—Leflunomide—systemic scleroderma	0.00216	0.00233	CcSEcCtD
Procaine—Oedema—Lisinopril—systemic scleroderma	0.00215	0.00233	CcSEcCtD
Procaine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00215	0.00233	CcSEcCtD
Procaine—Pruritus—Captopril—systemic scleroderma	0.00215	0.00232	CcSEcCtD
Procaine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00212	0.0023	CcSEcCtD
Procaine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00212	0.0023	CcSEcCtD
Procaine—Shock—Lisinopril—systemic scleroderma	0.00211	0.00229	CcSEcCtD
Procaine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00228	CcSEcCtD
Procaine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0021	0.00228	CcSEcCtD
Procaine—Tachycardia—Lisinopril—systemic scleroderma	0.0021	0.00227	CcSEcCtD
Procaine—Body temperature increased—Azathioprine—systemic scleroderma	0.00209	0.00227	CcSEcCtD
Procaine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00208	0.00225	CcSEcCtD
Procaine—Diarrhoea—Captopril—systemic scleroderma	0.00208	0.00225	CcSEcCtD
Procaine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00207	0.00224	CcSEcCtD
Procaine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00224	CcSEcCtD
Procaine—Fatigue—Mycophenolic acid—systemic scleroderma	0.00206	0.00223	CcSEcCtD
Procaine—Nausea—Mometasone—systemic scleroderma	0.00205	0.00222	CcSEcCtD
Procaine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00203	0.0022	CcSEcCtD
Procaine—Hypotension—Lisinopril—systemic scleroderma	0.00201	0.00217	CcSEcCtD
Procaine—Dizziness—Captopril—systemic scleroderma	0.00201	0.00217	CcSEcCtD
Procaine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.002	0.00216	CcSEcCtD
Procaine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00216	CcSEcCtD
Procaine—Urticaria—Leflunomide—systemic scleroderma	0.00199	0.00215	CcSEcCtD
Procaine—Body temperature increased—Leflunomide—systemic scleroderma	0.00198	0.00214	CcSEcCtD
Procaine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00213	CcSEcCtD
Procaine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00196	0.00212	CcSEcCtD
Procaine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00196	0.00212	CcSEcCtD
Procaine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00212	CcSEcCtD
Procaine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00195	0.00211	CcSEcCtD
Procaine—Vomiting—Captopril—systemic scleroderma	0.00193	0.00209	CcSEcCtD
Procaine—Rash—Captopril—systemic scleroderma	0.00191	0.00207	CcSEcCtD
Procaine—Dermatitis—Captopril—systemic scleroderma	0.00191	0.00207	CcSEcCtD
Procaine—Somnolence—Lisinopril—systemic scleroderma	0.00191	0.00207	CcSEcCtD
Procaine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00189	0.00204	CcSEcCtD
Procaine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00204	CcSEcCtD
Procaine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00204	CcSEcCtD
Procaine—BCHE—lung—systemic scleroderma	0.00186	0.0243	CbGeAlD
Procaine—Eosinophilia—Methotrexate—systemic scleroderma	0.00186	0.00201	CcSEcCtD
Procaine—Fatigue—Lisinopril—systemic scleroderma	0.00185	0.00201	CcSEcCtD
Procaine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00201	CcSEcCtD
Procaine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00184	0.002	CcSEcCtD
Procaine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00184	0.002	CcSEcCtD
Procaine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00184	0.00199	CcSEcCtD
Procaine—Bradycardia—Prednisone—systemic scleroderma	0.00183	0.00198	CcSEcCtD
Procaine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00197	CcSEcCtD
Procaine—Diarrhoea—Azathioprine—systemic scleroderma	0.00181	0.00196	CcSEcCtD
Procaine—Nausea—Captopril—systemic scleroderma	0.0018	0.00195	CcSEcCtD
Procaine—Hallucination—Prednisone—systemic scleroderma	0.00179	0.00194	CcSEcCtD
Procaine—Pruritus—Leflunomide—systemic scleroderma	0.00177	0.00192	CcSEcCtD
Procaine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00191	CcSEcCtD
Procaine—Dizziness—Azathioprine—systemic scleroderma	0.00175	0.0019	CcSEcCtD
Procaine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00172	0.00186	CcSEcCtD
Procaine—Diarrhoea—Leflunomide—systemic scleroderma	0.00171	0.00185	CcSEcCtD
Procaine—Urticaria—Lisinopril—systemic scleroderma	0.00171	0.00185	CcSEcCtD
Procaine—Body temperature increased—Lisinopril—systemic scleroderma	0.0017	0.00184	CcSEcCtD
Procaine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00169	0.00183	CcSEcCtD
Procaine—Vomiting—Azathioprine—systemic scleroderma	0.00168	0.00182	CcSEcCtD
Procaine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00181	CcSEcCtD
Procaine—Drowsiness—Methotrexate—systemic scleroderma	0.00167	0.00181	CcSEcCtD
Procaine—Rash—Azathioprine—systemic scleroderma	0.00167	0.00181	CcSEcCtD
Procaine—Dermatitis—Azathioprine—systemic scleroderma	0.00167	0.00181	CcSEcCtD
Procaine—Dizziness—Leflunomide—systemic scleroderma	0.00165	0.00179	CcSEcCtD
Procaine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00163	0.00177	CcSEcCtD
Procaine—Vomiting—Leflunomide—systemic scleroderma	0.00159	0.00172	CcSEcCtD
Procaine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00158	0.00171	CcSEcCtD
Procaine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00158	0.00171	CcSEcCtD
Procaine—Rash—Leflunomide—systemic scleroderma	0.00158	0.00171	CcSEcCtD
Procaine—Dermatitis—Leflunomide—systemic scleroderma	0.00158	0.00171	CcSEcCtD
Procaine—Nausea—Azathioprine—systemic scleroderma	0.00157	0.0017	CcSEcCtD
Procaine—Erythema—Prednisone—systemic scleroderma	0.00156	0.00169	CcSEcCtD
Procaine—Pruritus—Lisinopril—systemic scleroderma	0.00152	0.00165	CcSEcCtD
Procaine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00152	0.00164	CcSEcCtD
Procaine—Rash—Mycophenolic acid—systemic scleroderma	0.0015	0.00163	CcSEcCtD
Procaine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0015	0.00163	CcSEcCtD
Procaine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0015	0.00162	CcSEcCtD
Procaine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00161	CcSEcCtD
Procaine—Nausea—Leflunomide—systemic scleroderma	0.00149	0.00161	CcSEcCtD
Procaine—Vision blurred—Prednisone—systemic scleroderma	0.00147	0.0016	CcSEcCtD
Procaine—Diarrhoea—Lisinopril—systemic scleroderma	0.00147	0.00159	CcSEcCtD
Procaine—Agitation—Prednisone—systemic scleroderma	0.00144	0.00156	CcSEcCtD
Procaine—Angioedema—Prednisone—systemic scleroderma	0.00143	0.00155	CcSEcCtD
Procaine—Dizziness—Lisinopril—systemic scleroderma	0.00142	0.00154	CcSEcCtD
Procaine—Nausea—Mycophenolic acid—systemic scleroderma	0.00142	0.00153	CcSEcCtD
Procaine—Syncope—Prednisone—systemic scleroderma	0.0014	0.00152	CcSEcCtD
Procaine—Tinnitus—Methotrexate—systemic scleroderma	0.0014	0.00152	CcSEcCtD
Procaine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00139	0.0015	CcSEcCtD
Procaine—Loss of consciousness—Prednisone—systemic scleroderma	0.00137	0.00149	CcSEcCtD
Procaine—Vomiting—Lisinopril—systemic scleroderma	0.00137	0.00148	CcSEcCtD
Procaine—Rash—Lisinopril—systemic scleroderma	0.00135	0.00147	CcSEcCtD
Procaine—Convulsion—Prednisone—systemic scleroderma	0.00135	0.00147	CcSEcCtD
Procaine—Dermatitis—Lisinopril—systemic scleroderma	0.00135	0.00147	CcSEcCtD
Procaine—Hypertension—Prednisone—systemic scleroderma	0.00135	0.00146	CcSEcCtD
Procaine—Chills—Methotrexate—systemic scleroderma	0.00135	0.00146	CcSEcCtD
Procaine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00144	CcSEcCtD
Procaine—Arthralgia—Prednisone—systemic scleroderma	0.00133	0.00144	CcSEcCtD
Procaine—Anxiety—Prednisone—systemic scleroderma	0.00133	0.00144	CcSEcCtD
Procaine—Erythema—Methotrexate—systemic scleroderma	0.00131	0.00142	CcSEcCtD
Procaine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00139	CcSEcCtD
Procaine—Nausea—Lisinopril—systemic scleroderma	0.00128	0.00138	CcSEcCtD
Procaine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00128	0.00138	CcSEcCtD
Procaine—Oedema—Prednisone—systemic scleroderma	0.00128	0.00138	CcSEcCtD
Procaine—Shock—Prednisone—systemic scleroderma	0.00126	0.00136	CcSEcCtD
Procaine—Tachycardia—Prednisone—systemic scleroderma	0.00125	0.00135	CcSEcCtD
Procaine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00135	CcSEcCtD
Procaine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00123	0.00134	CcSEcCtD
Procaine—Vision blurred—Methotrexate—systemic scleroderma	0.00123	0.00133	CcSEcCtD
Procaine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0013	CcSEcCtD
Procaine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00129	CcSEcCtD
Procaine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00128	CcSEcCtD
Procaine—Leukopenia—Methotrexate—systemic scleroderma	0.00117	0.00127	CcSEcCtD
Procaine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00116	0.00126	CcSEcCtD
Procaine—Convulsion—Methotrexate—systemic scleroderma	0.00113	0.00123	CcSEcCtD
Procaine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00121	CcSEcCtD
Procaine—Arthralgia—Methotrexate—systemic scleroderma	0.00111	0.0012	CcSEcCtD
Procaine—Fatigue—Prednisone—systemic scleroderma	0.0011	0.00119	CcSEcCtD
Procaine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00107	0.00115	CcSEcCtD
Procaine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00104	0.00113	CcSEcCtD
Procaine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00103	0.00112	CcSEcCtD
Procaine—Urticaria—Prednisone—systemic scleroderma	0.00101	0.0011	CcSEcCtD
Procaine—Body temperature increased—Prednisone—systemic scleroderma	0.00101	0.00109	CcSEcCtD
Procaine—Hypotension—Methotrexate—systemic scleroderma	0.000997	0.00108	CcSEcCtD
Procaine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000972	0.00105	CcSEcCtD
Procaine—Somnolence—Methotrexate—systemic scleroderma	0.000948	0.00103	CcSEcCtD
Procaine—Hypersensitivity—Prednisone—systemic scleroderma	0.00094	0.00102	CcSEcCtD
Procaine—Fatigue—Methotrexate—systemic scleroderma	0.000919	0.000996	CcSEcCtD
Procaine—Pruritus—Prednisone—systemic scleroderma	0.000903	0.000978	CcSEcCtD
Procaine—Diarrhoea—Prednisone—systemic scleroderma	0.000873	0.000946	CcSEcCtD
Procaine—Urticaria—Methotrexate—systemic scleroderma	0.000847	0.000917	CcSEcCtD
Procaine—Dizziness—Prednisone—systemic scleroderma	0.000844	0.000914	CcSEcCtD
Procaine—Body temperature increased—Methotrexate—systemic scleroderma	0.000843	0.000913	CcSEcCtD
Procaine—Vomiting—Prednisone—systemic scleroderma	0.000811	0.000879	CcSEcCtD
Procaine—Rash—Prednisone—systemic scleroderma	0.000805	0.000871	CcSEcCtD
Procaine—Dermatitis—Prednisone—systemic scleroderma	0.000804	0.000871	CcSEcCtD
Procaine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000786	0.000851	CcSEcCtD
Procaine—Nausea—Prednisone—systemic scleroderma	0.000758	0.000821	CcSEcCtD
Procaine—Pruritus—Methotrexate—systemic scleroderma	0.000755	0.000817	CcSEcCtD
Procaine—Diarrhoea—Methotrexate—systemic scleroderma	0.00073	0.00079	CcSEcCtD
Procaine—Dizziness—Methotrexate—systemic scleroderma	0.000705	0.000764	CcSEcCtD
Procaine—Vomiting—Methotrexate—systemic scleroderma	0.000678	0.000734	CcSEcCtD
Procaine—Rash—Methotrexate—systemic scleroderma	0.000672	0.000728	CcSEcCtD
Procaine—Dermatitis—Methotrexate—systemic scleroderma	0.000672	0.000728	CcSEcCtD
Procaine—Nausea—Methotrexate—systemic scleroderma	0.000633	0.000686	CcSEcCtD
